Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients
Condition(s):Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedLast Updated:May 15, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedLast Updated:May 15, 2023Withdrawn
Condition(s):MelanomaLast Updated:April 27, 2021Completed
Condition(s):Head and Neck CancerLast Updated:January 10, 2022Completed
Condition(s):Large B-cell LymphomaLast Updated:November 29, 2023Recruiting
Condition(s):Rectal Cancer Stage; Oesophageal CancerLast Updated:March 15, 2024Recruiting
Condition(s):Metastatic Triple-Negative Breast CarcinomaLast Updated:October 4, 2023Recruiting
Condition(s):Lung Cancer; Melanoma; PD-L1; PET/CTLast Updated:March 29, 2023Recruiting
Condition(s):Solid Tumor, AdultLast Updated:July 26, 2021Unknown status
Condition(s):Gastrointestinal TumorsLast Updated:January 25, 2024Recruiting
Condition(s):NSCLC Stage IV; PD-L1 Gene AmplificationLast Updated:February 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.